Mark J. Ratain to Topoisomerase II Inhibitors
This is a "connection" page, showing publications Mark J. Ratain has written about Topoisomerase II Inhibitors.
Connection Strength
0.653
-
R(+)XK469 inhibits hydroxylation of S-warfarin by CYP2C9. Eur J Cancer. 2009 Jul; 45(11):1904-8.
Score: 0.338
-
Phase I clinical and pharmacogenetic study of weekly TAS-103 in patients with advanced cancer. J Clin Oncol. 2001 Apr 01; 19(7):2084-90.
Score: 0.192
-
Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genes. Ann Oncol. 1992 Feb; 3(2):107-11.
Score: 0.102
-
Etoposide pathway. Pharmacogenet Genomics. 2009 Jul; 19(7):552-3.
Score: 0.021